Smith & Nephew (SNN) Long-Term Deferred Tax (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Long-Term Deferred Tax of $347.0 million for Q4 2025, down 0.86% year-on-year from $350.0 million in Q4 2024, and down 13.47% on a QoQ basis from $401.0 million in Q2 2025.
Smith & Nephew (SNN) Long-Term Deferred Tax (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Long-Term Deferred Tax for 16 consecutive years, with $347.0 million the latest figure, recorded in Q4 2025.
- Quarterly Long-Term Deferred Tax fell 0.86% year-over-year to $347.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $347.0 million (down 0.86% YoY) and the FY2025 annual result came in at $347.0 million, down 0.86% from the prior year.
- Long-Term Deferred Tax retreated to $347.0 million in Q4 2025 per SNN's latest filing, from $401.0 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for SNN reached as high as $401.0 million in Q2 2025 and fell as low as $57.0 million in Q4 2021.
- A 5-year average of $269.9 million and a median of $319.0 million in 2024 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2021 — Long-Term Deferred Tax plunged 71.78% — and 2022, when it soared 147.37%.
- Year by year, Long-Term Deferred Tax stood at $57.0 million in 2021, then soared by 147.37% to $141.0 million in 2022, then soared by 94.33% to $274.0 million in 2023, then gained by 27.74% to $350.0 million in 2024, then decreased by 0.86% to $347.0 million in 2025.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $347.0 million, $401.0 million, and $350.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 347.00 Mn |
| Jun 28, 2025 | 401.00 Mn |
| Dec 31, 2024 | 350.00 Mn |
| Jun 29, 2024 | 319.00 Mn |
| Dec 31, 2023 | 274.00 Mn |
| Dec 31, 2022 | 141.00 Mn |
| Dec 31, 2021 | 57.00 Mn |
| Dec 31, 2020 | 202.00 Mn |
| Jun 30, 2020 | 224.00 Mn |
| Dec 31, 2019 | 150.00 Mn |
| Jun 29, 2019 | 134.00 Mn |
| Dec 31, 2018 | 126.00 Mn |
| Jun 30, 2018 | 129.00 Mn |
| Dec 31, 2016 | 97.00 Mn |
| Dec 31, 2015 | 105.00 Mn |
| Jun 30, 2015 | 75.00 Mn |
| Dec 31, 2014 | 77.00 Mn |
| Sep 30, 2014 | 90.00 Mn |
| Jun 28, 2014 | 84.00 Mn |
| Mar 31, 2014 | 134.00 Mn |